Friday, January 30, 2009

Dark financial outlook for CIRM

Dark Financial Outlook for CIRM Disclosed Tonight by David Jensen, California Stem Cell Report, January 29, 2009. Excerpts:
The financial condition of California's $3 billion stem cell agency tonight appeared bleak and "daunting," based on briefings provided to its 29-member board of directors.
CIRM's financial plight is the result of California's inability to sell state bonds because of the state's $40 billion budget crisis. CIRM relies on bond sales for funding. It has approved $635 million in grants, many covering several years, but currently does not have the cash to fund all of them.
The briefings disclosed that even if the state budget crisis were solved tomorrow, CIRM would face financial difficulties. That's because it takes time to bring bonds to market. Bonds supporting more critical needs would be sold well before the state would consider offering the CIRM bonds.


  1. Additional posts from the California Stem Cell Report:

    CIRM Says California Stem Cell Report is 'One-Sided' (January 30, 2009).

    Modest Coverage of CIRM Cash Problems (January 31, 2009).

    AP's Story on CIRM's Grants and Cash (January 31, 2009).

    A Look Inside the Financial Woes at the California Stem Cell Agency (February 01, 2009). Brief excerpt: "CIRM is also going ahead with requests for applications this month for its $210 million disease team round ...".

  2. More comments: Stem cell agency delays funding new grants by Krista Conger, Medical Center Report, Stanford School of Medicine, February 4, 2009.

    Found via: CIRM Board Member Pizzo writes about stem cell budget woes by David Jensen, California Stem Cell Report, February 4, 2009.